Study on the effectiveness of COVID-19 measures in the Netherlands The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.
Air pollution increases risk of infection and severity of illness from COVID-19 People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.
Number of tuberculosis patients in the Netherlands increased in 2023 compared to 2022 In 2023, 710 people in the Netherlands were diagnosed with tuberculosis (TB). This was 12 per cent more than in 2022, when there were 634. In 2023, 471 patients had pulmonary TB. Of these 417 patients, 213 had open TB – the most contagious type.
More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
Booster vaccinations reduced risk of death from COVID-19 in 2022 Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.
COVID-19 pandemic made me miss out on a key stage of my life, young people claim Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.
New version of NEVO with updated data on meat and dairy substitutes Today, RIVM will publish the new version of the Dutch Food Composition Database (Nederlands Voedingsstoffenbestand, NEVO). This contains information on the composition of more than 2,300 foods.
Vulnerable groups hit hardest by COVID-19 pandemic A new RIVM study has shown that the COVID-19 pandemic intensified existing socio-economic differences. People on lower incomes visited test lanes less often during the pandemic, but were admitted to hospital and intensive care with COVID-19 more often.
RIVM modelling for COVID-19 reviewed by international experts An international audit committee of scientific experts, commissioned by the RIVM Scientific Advisory Board, reviewed the institute’s COVID-19 data analytics and modelling work. These models and data formed a scientific basis for recommendations by the Outbreak Management Team (OMT) and others on COVID-19 control measures in the Netherlands.
Gastrointestinal symptoms on the rise, but still fewer than before the COVID-19 pandemic In 2022, the number of enteric infections – which mainly cause gastrointestinal symptoms – was higher than it was in the previous two years. However, the total number of infections was still lower than before the coronavirus pandemic.